These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3614385)

  • 1. Interconversion into a low active state protects vascular 5-HT2-receptors against irreversible antagonism by phenoxybenzamine.
    Frenken M; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):481-90. PubMed ID: 3614385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric properties of 5-HT2 receptors in tracheal smooth muscle.
    Lemoine H; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jun; 333(2):91-7. PubMed ID: 2944004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-state model for the 5-HT2 receptor: effects of alpha-adrenoceptor ligands.
    Kaumann AJ
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S88-92. PubMed ID: 2459522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric properties of the 5-HT2 receptor system of the rat tail artery. Ritanserin and methysergide are not competitive 5-HT2 receptor antagonists but allosteric modulators.
    Frenken M; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):359-66. PubMed ID: 3110629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A paradox: the 5-HT2-receptor antagonist ketanserin restores the 5-HT-induced contraction depressed by methysergide in large coronary arteries of calf. Allosteric regulation of 5-HT2-receptors.
    Kaumann AJ; Frenken M
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):295-300. PubMed ID: 3157064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tryptamine mediated through 2 states of the 5-HT2 receptor in calf coronary artery.
    Frenken M; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1988 May; 337(5):484-92. PubMed ID: 3137478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ageing is associated with increased 5-HT2-receptor affinity and decreased receptor reserve in rat isolated coronary arteries.
    Nyborg NC
    Br J Pharmacol; 1991 Jan; 102(1):282-6. PubMed ID: 2043930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further analysis of the inhibitory effects of dihydroergotamine, cyproheptadine and ketanserin on the responses of the rat aorta to 5-hydroxytryptamine.
    Doggrell SA
    J Auton Pharmacol; 1992 Aug; 12(4):223-36. PubMed ID: 1512277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ICI 169,369 is both a competitive antagonist and an allosteric activator of the arterial 5-hydroxytryptamine2 receptor system.
    Kaumann AJ; Frenken M
    J Pharmacol Exp Ther; 1988 Jun; 245(3):1010-5. PubMed ID: 3385635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Hydroxytryptamine (5-HT) contracts the guinea-pig isolated iliac artery via 5-HT1-like and 5-HT2 receptors.
    Pertz H
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Dec; 348(6):558-65. PubMed ID: 8133899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethylation of the activator ICI 169,369 results in a high-affinity partial deactivator, ICI 170,809, of the arterial 5-hydroxytryptamine2 receptor system.
    Frenken M; Kaumann AJ
    J Pharmacol Exp Ther; 1989 Aug; 250(2):707-13. PubMed ID: 2760851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptaminergic receptors in the bovine pulmonary vasculature: effects of ketanserin.
    Ogunbiyi PO; Eyre P
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):31-55. PubMed ID: 6328601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competitive antagonism by recognized 5-HT2 receptor antagonists at 5-HT1C receptors in pig choroid plexus.
    Sahin-Erdemli I; Schoeffter P; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Aug; 344(2):137-42. PubMed ID: 1944609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actions of non-peptide ergot alkaloids at 5-HT1-like and 5-HT2 receptors mediating vascular smooth muscle contraction.
    MacLennan SJ; Martin GR
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):120-9. PubMed ID: 2234096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors.
    Kaumann AJ; Frenken M; Posival H; Brown AM
    Circulation; 1994 Sep; 90(3):1141-53. PubMed ID: 8087924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT1-like receptors requiring functional cyclo-oxygenase and 5-HT2 receptors independent of cyclo-oxygenase mediate contraction of the human umbilical artery.
    MacLennan SJ; Whittle MJ; McGrath JC
    Br J Pharmacol; 1989 Jul; 97(3):921-33. PubMed ID: 2503229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential antagonism of the initial fast and secondary slow contractile responses of the rat isolated aorta to 5-hydroxytryptamine by mianserin and ketanserin.
    Doggrell SA
    J Auton Pharmacol; 1987 Jun; 7(2):157-64. PubMed ID: 3654683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of 5-hydroxytryptamine receptors mediating contractions in basilar arteries from stroke-prone spontaneously hypertensive rats.
    Nishimura Y
    Br J Pharmacol; 1996 Mar; 117(6):1325-1333. PubMed ID: 8882632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketanserin causes surmountable antagonism of 5-hydroxytryptamine-induced contractions of large coronary arteries of dog.
    Frenken M; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):301-3. PubMed ID: 3157065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
    Kemp BK; Cocks TM
    Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.